Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $509M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS INC | 1,212,096 | $32.24M | 6.3% | $16.07 | +77.1% | COM | 729139105 |
| XENE | XENON PHARMACEUTICALS INC | 818,505 | $29.29M | 5.8% | $22.27 | +65.9% | COM | 98420N105 |
| — | ALPINE IMMUNE SCIENCES INC | 3,740,761 | $28.88M | 5.7% | $7.41 | — | COM | 02083G100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 677,426 | $27.16M | 5.3% | $41.10 | +4.4% | COM | 90400D108 |
| — | RAPT THERAPEUTICS INC | 1,355,151 | $24.87M | 4.9% | $20.73 | — | COM | 75382E109 |
| PCVX | VAXCYTE INC | 659,211 | $24.71M | 4.9% | $26.90 | +57.7% | COM | 92243G108 |
| — | POINT BIOPHARMA GLOBAL INC | 3,383,029 | $24.59M | 4.8% | $7.55 | — | COM | 730541109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 783,795 | $23M | 4.5% | $34.92 | -0.5% | COM | 03237H101 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,003,000 | $22.56M | 4.4% | $23.16 | -8.2% | COM | 89422G107 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 149,500 | $21.88M | 4.3% | $147.36 | +0.4% | SHS USD | G50871105 |
| EOLS | EVOLUS INC | 2,192,816 | $18.55M | 3.6% | $8.93 | +1.3% | COM | 30052C107 |
| CYTK | CYTOKINETICS INC | 500,000 | $17.59M | 3.5% | $40.80 | 0.0% | COM NEW | 23282W605 |
| ANAB | ANAPTYSBIO INC | 804,333 | $17.5M | 3.4% | $24.38 | -0.3% | COM | 032724106 |
| — | IVERIC BIO INC | 694,009 | $16.89M | 3.3% | $21.41 | — | COM | 46583P102 |
| VKTX | VIKING THERAPEUTICS INC | 1,000,000 | $16.65M | 3.3% | $4.46 | +131.4% | COM | 92686J106 |
| — | AEROVATE THERAPEUTICS INC | 755,620 | $15.24M | 3.0% | $24.74 | — | COM | 008064107 |
| — | OPTINOSE INC | 7,894,736 | $15.24M | 3.0% | $1.85 | — | COM | 68404V100 |
| IMCR | IMMUNOCORE HLDGS PLC | 255,367 | $12.63M | 2.5% | $49.44 | — | ADS | 45258D105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,600,545 | $12.58M | 2.5% | $11.36 | -34.3% | COM | 483497103 |
| RLAY | RELAY THERAPEUTICS INC | 658,127 | $10.84M | 2.1% | $17.93 | 0.0% | COM | 75943R102 |
| MLYS | MINERALYS THERAPEUTICS INC | 620,326 | $9.714M | 1.9% | $16.83 | 0.0% | COM | 603170101 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,191,581 | $9.64M | 1.9% | $14.85 | -14.5% | COM | 00461U105 |
| HRTX | HERON THERAPEUTICS INC | 5,817,368 | $8.784M | 1.7% | $3.84 | -34.7% | COM | 427746102 |
| ACLX | ARCELLX INC | 257,006 | $7.918M | 1.6% | $30.34 | 0.0% | COMMON STOCK | 03940C100 |
| — | PRECISION BIOSCIENCES INC | 8,099,799 | $6.104M | 1.2% | $1.10 | — | COM | 74019P108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 278,334 | $5.954M | 1.2% | $6.97 | +141.3% | CLASS A ORD | 61559X104 |
| — | GRACELL BIOTECHNOLOGIES INC | 3,153,206 | $5.865M | 1.2% | $2.26 | — | SPONSORED ADS | 38406L103 |
| — | CYMABAY THERAPEUTICS INC | 507,500 | $4.425M | 0.9% | $4.84 | — | COM | 23257D103 |
| — | GENERATION BIO CO | 1,022,537 | $4.397M | 0.9% | $5.04 | — | COM | 37148K100 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 1,051,267 | $4.268M | 0.8% | $4.79 | +9.1% | COM | 00509G209 |
| FOLD | AMICUS THERAPEUTICS INC | 380,000 | $4.214M | 0.8% | $12.33 | 0.0% | COM | 03152W109 |
| LRMR | LARIMAR THERAPEUTICS INC | 900,000 | $4.077M | 0.8% | $2.60 | +100.6% | COM | 517125100 |
| — | INTRA-CELLULAR THERAPIES INC | 70,371 | $3.811M | 0.7% | $54.15 | — | COM | 46116X101 |
| — | 89BIO INC | 250,000 | $3.808M | 0.7% | $15.23 | — | COM | 282559103 |
| ACRS | ACLARIS THERAPEUTICS INC | 250,000 | $2.022M | 0.4% | $14.85 | -14.5% | Call | 00461U105 |
| ZVRA | ZEVRA THERAPEUTICS INC | 347,824 | $1.913M | 0.4% | $5.29 | 0.0% | COM NEW | 488445206 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 141,526 | $1.892M | 0.4% | $20.61 | -5.2% | COM | 23954D109 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 97,544 | $1.74M | 0.3% | $25.11 | 0.0% | COM | 76243J105 |
| — | PRAXIS PRECISION MEDICINES I | 2,032,550 | $1.644M | 0.3% | $0.81 | — | COM | 74006W108 |
| VKTX | VIKING THERAPEUTICS INC | 80,000 | $1.332M | 0.3% | $4.46 | +131.4% | Put | 92686J106 |
| SLDB | SOLID BIOSCIENCES INC | 210,405 | $997K | 0.2% | $6.01 | 0.0% | COM NEW | 83422E204 |
| — | AVALO THERAPEUTICS INC | 474,639 | $831K | 0.2% | $1.75 | — | COM NEW | 05338F207 |
| — | RENEO PHARMACEUTICALS INC | 120,864 | $723K | 0.1% | $5.98 | — | COM | 75974E103 |
| URGN | UROGEN PHARMA LTD | 39,222 | $362K | 0.1% | $15.60 | -41.0% | COM | M96088105 |